2024
Improving Guideline-Concordant Care for Febrile Infants Through a Quality Improvement Initiative.
McDaniel C, Kerns E, Jennings B, Magee S, Biondi E, Flores R, Aronson P. Improving Guideline-Concordant Care for Febrile Infants Through a Quality Improvement Initiative. 2024, 153 PMID: 38682245, DOI: 10.1542/peds.2023-063339.Peer-Reviewed Original ResearchConceptsClinical practice guidelinesFebrile infantsAmerican Academy of Pediatrics clinical practice guidelineSecondary measuresAAP clinical practice guidelinesPediatrics clinical practice guidelineInvasive bacterial infectionsQI collaborativeIntervention bundleAdherence to specific recommendationsDischarge of infantsGuideline-concordant careInfants aged 8Clinical practice guideline recommendationsPrimary measureQuality improvementOral antibioticsEmergency department dischargePositive urinalysisAssociated with improvementsQualifying infantsQuality improvement initiativesAdministered antibioticsGuideline recommendationsCerebrospinal fluid
2022
Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017
Nejad M, Ahmadi N, Mohammadi E, Shabani M, Sherafati A, Aryannejad A, Rezaei N, Ghanbari A, Yoosefi M, Aminorroaya A, Shabani M, Rezaei N, Salavati T, Larijani B, Naderimagham S, Farzadfar F. Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017. International Journal For Quality In Health Care 2022, 34: mzac026. PMID: 35434737, DOI: 10.1093/intqhc/mzac026.Peer-Reviewed Original ResearchConceptsQuality of care indexGlobal Burden of DiseaseNon-rheumatic valvular heart diseaseQuality of careSociodemographic indexBurden of diseaseQuality of care index scoreLow SDI quintileWHO world regionsSociodemographic index countriesHeart diseaseHealthcare qualityHealthcare accessCare indexEastern Mediterranean RegionHealthcare systemRegional burdenGlobal burdenWestern Pacific RegionValvular heart diseaseHealthcareAge groupsQuintilePrimary measureCareAn Initiative to Improve Performance on a National Transition of Care Measure and to Reduce Readmissions in an Academic Psychiatric Hospital
Li L, Kulp W, Krieg H, Aptaker D, Klink B, Knox D, Pincus HA. An Initiative to Improve Performance on a National Transition of Care Measure and to Reduce Readmissions in an Academic Psychiatric Hospital. The Joint Commission Journal On Quality And Patient Safety 2022, 48: 205-213. PMID: 35193810, DOI: 10.1016/j.jcjq.2022.01.002.Peer-Reviewed Original ResearchConceptsQuality improvement projectReadmission ratesPsychiatric hospitalCompliance rateCause readmission rateDecrease hospital readmissionsClinical decision support toolAcademic psychiatric hospitalAdverse patient outcomesImprovement projectClinical diagnosis dataHospital readmissionPreintervention periodCare measuresPatient outcomesCDS toolProvider complianceReadmissionCDS toolsHospitalOutcome metricsPrimary measureYear 2Year 3Diagnosis data
2021
Direct observation in a large-scale randomized trial of parent training in children with autism spectrum disorder and disruptive behavior
Swiezy N, Smith T, Johnson CR, Bearss K, Lecavalier L, Drill R, Warner D, Deng Y, Xu Y, Dziura J, Handen B, Scahill L. Direct observation in a large-scale randomized trial of parent training in children with autism spectrum disorder and disruptive behavior. Research In Autism Spectrum Disorders 2021, 89: 101879. PMID: 34950225, PMCID: PMC8691726, DOI: 10.1016/j.rasd.2021.101879.Peer-Reviewed Original ResearchAutism spectrum disorderDisruptive behaviorParent trainingSpectrum disorderParent ratingsParentchild interactionChild behaviorObservation measuresResource-intensive effortsChild participantsParent educationYoung childrenSame measuresLaboratory settingChildrenSOAP dataPrimary measureMeasuresModerate levelsTrainingPrimary purposeDisordersStudy entry criteriaBehaviorOutcome measuresA global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017
Mohammadi E, Ghasemi E, Azadnajafabad S, Rezaei N, Moghaddam S, Meimand S, Fattahi N, Habibi Z, Yarandi K, Amirjamshidi A, Nejat F, Kompani F, Mokdad A, Larijani B, Farzadfar F. A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017. PLOS ONE 2021, 16: e0247120. PMID: 33617563, PMCID: PMC7899371, DOI: 10.1371/journal.pone.0247120.Peer-Reviewed Original ResearchConceptsQuality of care indexQuality of careSocio-demographic IndexGlobal Burden of DiseaseCare indexLowest QCIsGlobal burdenHigher socio-demographic indexBurden of diseaseCentral nervous system cancerNervous system cancersCare qualityCancer careSocioeconomic patternsCentral nervous systemWestern Pacific RegionCareEpidemiological measuresNational surveyGroup of cancersSystem cancersPrimary measurePrimary brainLethal diagnosisBurden
2018
A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees
Bold KW, Kimmel L, Hanrahan TH, Romano D, Rojewski AM, Krishnan-Sarin S, Fucito LM, O’Malley S. A Pilot Clinical Trial of Smoking Cessation Services Implemented in the Workplace for Service Industry Employees. American Journal Of Health Promotion 2018, 33: 516-524. PMID: 30153737, PMCID: PMC7259449, DOI: 10.1177/0890117118795987.Peer-Reviewed Original ResearchConceptsSmoking cessation servicesService industry employeesCessation servicesQuit attemptsIndustry employeesEvidence-based tobacco treatmentPilot clinical trialEnd of treatmentFree pharmacotherapyTobacco treatmentPreliminary efficacyHelpful overallClinical trialsSmoking treatmentSuccessful abstinenceContingency managementEmployeesIndividual counselingTreatmentStatus SurveyPrimary measureService settingsHigh rateWorkplaceAbstinenceAccuracy and Acceptability of a Screening Tool for Identifying Intimate Partner Violence Perpetration among Women Veterans: A Pre-Implementation Evaluation
Portnoy GA, Haskell SG, King MW, Maskin R, Gerber MR, Iverson KM. Accuracy and Acceptability of a Screening Tool for Identifying Intimate Partner Violence Perpetration among Women Veterans: A Pre-Implementation Evaluation. Women's Health Issues 2018, 28: 439-445. PMID: 29885901, DOI: 10.1016/j.whi.2018.04.003.Peer-Reviewed Original ResearchConceptsWomen veteransLow-burden toolVeterans Health AdministrationIntimate partner violenceHealth care providersMajority of womenAppropriate referralIPV perpetrationCare providersPre-implementation evaluationHealth AdministrationWeb-based surveyHealthcare settingsScreening toolLimited evidenceVeteransWomen's perceptionsPrimary measureReference standardIntimate Partner Violence PerpetrationWomenNational samplePresent studyPartner violencePartner violence perpetration
2016
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani H, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. European Journal Of Heart Failure 2016, 18: 482-489. PMID: 27071916, DOI: 10.1002/ejhf.516.Peer-Reviewed Original ResearchConceptsHeart failure clinical trialsComposite endpointClinical trialsNew composite endpointHeart failureHeart failure treatmentEffect of therapyHealth system perspectiveOverall treatment effectRepeat hospitalizationPlanned trialsFunctional statusFailure treatmentOutcome eventsPatient burdenEfficacy assessmentPatient experienceNew treatmentsTrialsAdverse effectsEfficiency of trialsEndpointTrial efficiencyTreatment effectsPrimary measureEvaluating the effectiveness of localized control strategies to curtail chikungunya
Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP. Evaluating the effectiveness of localized control strategies to curtail chikungunya. Scientific Reports 2016, 6: 23997. PMID: 27045523, PMCID: PMC4820747, DOI: 10.1038/srep23997.Peer-Reviewed Original ResearchConceptsAcute febrile phaseChronic joint painRe-emerging arbovirusOutbreak of chikungunyaJoint painFebrile phaseSymptomatic casesChikungunya casesChikungunya outbreakTropical diseasesDiseaseAlbopictus mosquitoesDisease surveillanceChikungunyaTransmission dynamicsPrimary measureVector control effortsAedes aegyptiMosquito movementContainment strategiesOutbreakSubsequent spreadVector controlMosquitoesPain
2015
Validation of a Brief Measure of Opioid Dependence
Wickersham JA, Azar MM, Cannon CM, Altice FL, Springer SA. Validation of a Brief Measure of Opioid Dependence. Journal Of Correctional Health Care 2015, 21: 12-26. PMID: 25559628, PMCID: PMC4435561, DOI: 10.1177/1078345814557513.Peer-Reviewed Original ResearchConceptsOpioid dependencePredictive valueMini International Neuropsychiatric InterviewModerate diagnostic agreementHIV-positive individualsInternational Neuropsychiatric InterviewNegative predictive valuePositive predictive valueAverage administrationNeuropsychiatric InterviewInter-item correlationsMental disordersDiagnostic agreementStatistical ManualStrong internal consistencyComprehensive interviewPrimary measureFourth EditionInternal consistencyPsychometric propertiesResearch settingsBrief measureConcordance analysisInitial validationAdministration
2009
Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial
Aman MG, Mcdougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, Kohn AE, Koenig K, Hollway JA, Korzekwa P, Gavaletz A, Mulick JA, Hall KL, Dziura J, Ritz L, Trollinger S, Yu S, Vitiello B, Wagner A, Network F. Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial. Journal Of The American Academy Of Child & Adolescent Psychiatry 2009, 48: 1143-1154. PMID: 19858761, PMCID: PMC3142923, DOI: 10.1097/chi.0b013e3181bfd669.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderClinical trialsClinical Global Impressions-Improvement scoreAberrant Behavior Checklist IrritabilityParallel-group clinical trialParent trainingBehavioral problemsDevelopmental disordersRisperidone doseRisperidone monotherapyHyperactivity/noncompliance subscaleSevere behavioral problemsCOMB groupPT sessionsQuestionnaire scoresHSQ scoresMedicationsGreater reductionChildrenPrimary measureRisperidoneSignificant reductionStereotypic behaviorScoresDose
2003
Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials
ARNOLD L, VITIELLO B, MCDOUGLE C, SCAHILL L, SHAH B, GONZALEZ N, CHUANG S, DAVIES M, HOLLWAY J, AMAN M, CRONIN P, KOENIG K, KOHN A, MCMAHON D, TIERNEY E. Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials. Journal Of The American Academy Of Child & Adolescent Psychiatry 2003, 42: 1443-1450. PMID: 14627879, DOI: 10.1097/00004583-200312000-00011.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAffectAggressionAutistic DisorderChildClinical Trials as TopicDopamine AntagonistsDouble-Blind MethodEndpoint DeterminationFemaleHumansMaleObserver VariationParent-Child RelationsPlacebosResearch DesignRisperidoneSeverity of Illness IndexStereotyped BehaviorTreatment OutcomeConceptsAberrant Behavior Checklist-Irritability subscaleClinical trialsIrritability subscaleClinical Global Impression-ImprovementDouble-blind trialPediatric Psychopharmacology Autism NetworkChief complaintCommon symptomsTarget symptomsEfficacy assessmentIrritable behaviorSymptom categoriesRisperidoneChange scoresSymptomsEffect size dInterrater reliabilityTrialsPlaceboTreatment effectsClinical applicationPrimary measureConsumer-friendly wayWeeksAutism Network
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply